Exhibit 10.1
GILEAD SCIENCES,
INC.
2004 EQUITY
INCENTIVE PLAN (1)
AS AMENDED AND RESTATED MAY 6,
2009
1. Purpose of the Plan . The
purpose of this Plan is to provide incentives to attract, retain
and motivate eligible persons whose present and potential
contributions are important to the success of the Company by
offering them an opportunity to participate in the Company’s
future performance. This Plan was originally approved by
stockholders at the 2004 Annual Stockholders Meeting and serves as
the successor to the Gilead Sciences, Inc. 1991 Stock Option Plan
and the Gilead Sciences, Inc. 1995 Non-Employee Directors’
Stock Option Plan. No further option grants will be made under
those plans, and the remaining shares available for issuance under
those plans have been transferred to this Plan ad are available for
issuance under this Plan.
The October 2007 restatement
expanded the list of performance criteria to which the vesting of
one or more Awards may be tied, including Awards designed to
provide Performance-Based Compensation, and effected a series of
technical revisions to the Plan in order to facilitate the
administration of the Plan and provide additional flexibility in
structuring Awards.
The January 30, 2008
restatement adopted by the Board effected the following changes to
the Plan, subject to stockholder approval at the 2008 Annual
Meeting: (i) increased the authorized share reserve under the
Plan by an additional 10,000,000 shares of Common Stock and
(ii) increased the limit on the maximum number of shares of
Common Stock for which “full value” Awards may be made
over the term of the Plan by an additional 5,000,000 shares. The
Company’s stockholders approved such increases at the 2008
Annual Meeting held on May 8, 2008.
This May 2009 restatement effects
the following changes to the Plan approved by the Board, subject to
stockholder approval at the 2009 Annual Meeting: (i) increases
the authorized share reserve by an additional 20,000,000 shares of
Common Stock, (ii) increased the limit on the maximum number
of shares that may be issued under the Plan pursuant to full-value
awards, such as restricted stock, restricted stock units,
performance shares, performance units (to the extent settled in
Common Stock) and phantom shares, by an additional 15,000,000
shares to a total of 25,000,000 over the term of the Plan,
(iii) increased the limit on the maximum number of shares of
Common Stock for which restricted stock, restricted stock units,
performance shares, performance units, phantom shares and stock
appreciation rights may be granted to any one individual per
calendar year by an additional 600,000 shares to a total of
1,000,000 shares, and (iv) increased the limit on the maximum
value of awards denominated in U.S. dollars that may be granted to
any one individual per calendar year by an additional $3,000,000 to
a total of $10,000,000. The Company’s stockholders approved
such increases at the 2009 Annual Meeting held on May 6,
2009.
2. Definitions . As used
herein, the following definitions shall apply:
(a) “ Administrator
” means the Board or any of the Committees appointed to
administer the Plan.
(b) “ Applicable
Acceleration Period ” means: (i) 24 months, in the
case of the Company’s Chief Executive Officer, (ii) 18
months, in the case of an Executive Vice President or Senior Vice
President of the Company, and (iii) 12 months, in the case of
all other Grantees.
(c) “ Applicable Laws
” means the legal requirements relating to the Plan and the
Awards under applicable provisions of federal securities laws,
state corporate and securities laws, the Code, the rules of any
applicable stock exchange, and the rules of any non-U.S.
jurisdiction applicable to Awards granted to residents
therein.
(d) “ Award ”
means the grant of an Option, SAR, Dividend Equivalent Right,
Restricted Stock, Restricted Stock Unit, Performance Unit,
Performance Share, Phantom Share, or other right or benefit under
the Plan.
(e) “ Award Agreement
” means the written agreement evidencing the grant of an
Award executed by the Company and the Grantee, including any
amendments thereto.
(f) “ Board ”
means the Board of Directors of the Company.
|
(1)
|
Includes amendments through
May 6, 2009, including the amendments approved by the
stockholders at the annual stockholders meeting held on such date.
All share numbers have been adjusted to reflect the two-for-one
stock split of the Common Stock effective September 3, 2004
and the two-for-one stock split of the Common Stock effective
June 22, 2007.
|
(g) “ Cause ”
means, with respect to the termination by the Company or a Related
Entity of the Grantee’s Continuous Service, that such
termination is for one or more of the reasons set forth in the
definition of “Cause” as such term is expressly defined
in a then-effective written agreement between the Grantee and the
Company or such Related Entity, or in the a merger, consolidation
or other reorganization approved by the Company’s
stockholders, unless securities representing more than fifty
percent (50%) of the total combined voting power of the voting
securities of the successor corporation are immediately thereafter
beneficially owned, directly or indirectly and in substantially the
same proportion, by the persons who beneficially owned the
Company’s outstanding voting securities immediately prior to
such transaction, absence of such then-effective written agreement
and definition, is based on, in the determination of the
Administrator, the Grantee’s: (i) performance of any
act, or failure to perform any act, in bad faith and to the
detriment of the Company or a Related Entity; (ii) dishonesty,
intentional misconduct, material violation of any applicable
Company or Related Entity policy, or material breach of any
agreement with the Company or a Related Entity; or
(iii) commission of a crime involving dishonesty, breach of
trust, or physical or emotional harm to any person.
(h) “ Change in Control
” means, for purposes of all Awards at the time outstanding
under the Plan, a change in ownership or control of the Company
effected through the consummation of any of the following
transactions:
(i) a sale, transfer or other
disposition of all or substantially all of the Company’s
assets,
(ii) the closing of any transaction
or series of related transactions pursuant to which any person or
any group of persons comprising a “group” within the
meaning of Rule 13d-5(b)(1) of the 1934 Act (other than the Company
or a person that, prior to such transaction or series of related
transactions, directly or indirectly controls, is controlled by or
is under common control with, the Company) becomes directly or
indirectly (whether as a result of a single acquisition or by
reason of one or more acquisitions within the twelve (12)-month
period ending with the most recent acquisition) the beneficial
owner (within the meaning of Rule 13d-3 of the 1934 Act) of
securities possessing (or convertible into or exercisable for
securities possessing) more than fifty percent (50%) of the
total combined voting power of the Company’s securities (as
measured in terms of the power to vote with respect to the election
of Board members) outstanding immediately after the consummation of
such transaction or series of related transactions, whether such
transaction involves a direct issuance from the Company or the
acquisition of outstanding securities held by one or more of the
Company’s existing stockholders, or
(iii) a change in the composition of
the Board over a period of twelve (12) consecutive months or
less such that a majority of the Board members ceases, by reason of
one or more contested elections for Board membership, to be
comprised of individuals who either (A) have been Board
members continuously since the beginning of such period or
(B) have been elected or nominated for election as Board
members during such period by at least a majority of the Board
members described in clause (A) who were still in office at
the time the Board approved such election or nomination.
In no event, however, shall a Change
in Control be deemed to occur upon a merger, consolidation or other
reorganization effected primarily to change the State of the
Company’s incorporation or to create a holding company
structure pursuant to which the Company becomes a wholly-owned
subsidiary of an entity whose outstanding voting securities
immediately after its formation are beneficially owned, directly or
indirectly and in substantially the same proportion, by the persons
who beneficially owned the Company’s outstanding voting
securities immediately prior to the formation of such
entity.
(i) “ Code ”
means the Internal Revenue Code of 1986, as amended.
(j) “ Committee ”
means any committee composed of members of the Board appointed by
the Board to administer the Plan.
(k) “ Common Stock
” means the common stock of the Company.
(l) “ Company ”
means Gilead Sciences, Inc., a Delaware corporation.
(m) “ Consultant
” means any person, including an advisor, who is compensated
by the Company or any Related Entity for services performed as a
non-employee consultant; provided, however, that the term
“Consultant” shall not include non-employee Directors
serving in their capacity as Board members. The term
“Consultant” shall include a member of the board of
directors of a Related Entity.
2
(n) “ Continuous
Service ” means the performance of services for the
Company or a Related Entity (whether now existing or subsequently
established) by a person in the capacity of an Employee, a Director
or a Consultant, except to the extent otherwise specifically
provided in the documents evidencing the Award. For purposes of the
Plan, a Grantee shall be deemed to cease Continuous Service
immediately upon the occurrence of either of the following events:
(i) the Grantee no longer performs services in any of the
foregoing capacities for the Company or any Related Entity or
(ii) the entity for which the Grantee is performing such
services ceases to remain a Related Entity of the Company, even
though the Grantee may subsequently continue to perform services
for that entity. Continuous Service shall not be deemed to cease
during a period of military leave, sick leave or other personal
leave approved by the Company; provided, however, that should such
leave of absence exceed three (3) months, then for purposes of
determining the period within which an Incentive Option may be
exercised as such under the federal tax laws, the Grantee shall be
deemed to have terminated Employee status on the first day
immediately following the expiration of such three (3)-month
period, unless such Grantee is provided with the right to return to
Continuous Service following such leave either by statute or by
written contract. The Grantee shall not receive any Continuous
Service credit, for purposes of vesting in any outstanding Award or
Awards made to the Grantee, for any period such Grantee is on a
leave of absence, except to the extent otherwise required by law or
pursuant to the following procedure:
|
|
•
|
|
A Grantee shall receive
Continuous Service credit for such vesting purposes for
(i) the first three months of an approved personal leave of
absence and (ii) the first seven months of any bona fide leave
of absence (other than an approved personal leave), but in no event
beyond the expiration date of such leave of absence;
provided, however, that in the event the
Grantee’s Award is subject to Section 409A of the Code
and payable upon his or her separation from service, then the
maximum period for which such Continuous Service credit shall be
given with respect to that Award shall be determined in accordance
with Treasury Regulations Section 1.409A-1(h) and accordingly
shall not extend beyond the date the Grantee is deemed to have a
separation from service for purposes of
Section 409A.
|
In jurisdictions requiring notice in
advance of an effective termination of a Grantee’s service as
an Employee, Director or Consultant, Continuous Active Service
shall be deemed terminated upon the actual cessation of such
service to the Company or a Related Entity notwithstanding any
required notice period that must be fulfilled before such
individual’s termination as an Employee, Director or
Consultant can be effective under Applicable Laws.
A Grantee on an approved leave of
absence shall be deemed to terminate Continuous Service for
purposes of his or her outstanding Awards upon the earlier of
(i) the expiration date of that leave of absence, unless such
Grantee returns to active Continuous Service on or before that
date, or (ii) the date the Grantee’s Continuous Service
actually terminates by reason of his or her voluntary or
involuntary termination or by reason of his or her death or
disability; provided, however, that in the event the
Grantee’s Award is subject to Section 409A of the Code
and payable upon his or her separation from service, then his or
her Continuous Service shall, with respect to that Award, be deemed
to terminate when such Grantee is deemed to have a separation from
service under Treasury Regulations
Section 1.409A-1(h).
(o) “ Covered Employee
” means an Employee who is a “covered employee”
under Section 162(m)(3) of the Code.
(p) “ Director ”
means a member of the Board.
(q) “ Dividend Equivalent
Right ” means a right entitling the Grantee to
compensation measured by dividends paid with respect to the Common
Stock underlying his or her Award (other than an Option or SAR
Award).
(r) “ Domestic Partner
” means a person who meets and continues to meet all of the
criteria detailed in the Gilead Sciences Affidavit of Domestic
Partnership when the Domestic Partnership has been internally
registered with the Company by filing with the Company an original,
properly completed, notarized Gilead Sciences Affidavit of Domestic
Partnership.
(s) “ Employee ”
means any person, including an Officer or Director, who is in the
employ of the Company or any Related Entity, subject to the control
and direction of the Company or any Related Entity as to both the
work to be performed and the manner and method of performance.
Neither service as a Director nor payment of a director’s fee
by the Company or a Related Entity shall be sufficient to
constitute “employment” by the Company.
3
(t) “ Exchange Act
” means the Securities Exchange Act of 1934, as
amended.
(u) “ Fair Market Value
” means, as of any date, the value of Common Stock determined
as follows:
For Awards made prior to May 1,
2009 (or Awards made on or after that date pursuant to commitments
under outstanding offer letters or other agreements made before
that date):
(i) If the Common Stock is on the
date of determination listed on any established stock exchange,
including without limitation the NASDAQ Global or Global Select
Market, the American Stock Exchange or the New York Stock Exchange,
its Fair Market Value shall be the closing sales price for such
stock (or the closing bid, if no sales were reported) as quoted on
such exchange (or the exchange with the greatest volume of trading
in the Common Stock) on the last market trading day prior to the
date of determination as such quotation is reported in The Wall
Street Journal or such other source as the Board deems reliable;
or
(ii) If the Common Stock is on the
date of determination regularly quoted on an automated quotation
system (including the OTC Bulletin Board) or by a recognized
securities dealer, but selling prices are not reported, the Fair
Market Value per share of Common Stock shall be the mean between
the high bid and high asked prices for the Common Stock on the last
market trading day prior to the date of determination, as reported
in The Wall Street Journal or such other source as the Board deems
reliable.
For Awards made on or after
May 1, 2009 (other than Awards which the Company is committed
to make on or after that date pursuant to outstanding offer letters
or other agreements made before that date):
(iii) If the Common Stock is on the
date of determination listed on any established stock exchange,
including without limitation the NASDAQ Global or Global Select
Market, the American Stock Exchange or the New York Stock Exchange,
its Fair Market Value shall be the closing sales price for such
stock (or the closing bid, if no sales were reported) as quoted on
such exchange (or the exchange with the greatest volume of trading
in the Common Stock) on the date of determination (or, if no
closing sales price or closing bid was quoted on that date, as
applicable, on the last trading date such closing sales price or
closing bid was quoted, as the applicable quoted price is reported
in The Wall Street Journal or such other source as the Board deems
reliable; or
(iv) If the Common Stock is on the
date of determination regularly quoted on an automated quotation
system (including the OTC Bulletin Board) or by a recognized
securities dealer, but selling prices are not reported, the Fair
Market Value per share of Common Stock shall be the mean between
the high bid and high asked prices for the Common Stock on the date
of determination (or, if no such prices were reported on that date,
on the last date such prices were quoted , as the applicable quoted
prices are reported in The Wall Street Journal or such other source
as the Board deems reliable.
For all Awards:
(v) In the absence of an established
market for the Common Stock of the type described in (i) and
(ii), above, the Fair Market Value thereof shall, for purposes of
any Award other than an Incentive Stock Option, be determined by
the Board through the reasonable application of a reasonable
valuation method that takes into account the applicable valuation
factors set forth in the Treasury Regulations issued under
Section 409A of the Code and shall, for purposes of an
Incentive Stock Option, be determined by the Board in good faith in
accordance with the standards of Section 422 of the Code and
the applicable Treasury Regulations thereunder.
(v) “ Grantee ”
means an Employee, Director or Consultant who receives an Award
under the Plan.
(w) “ Immediate Family
” means any child, stepchild, grandchild, parent, stepparent,
grandparent, spouse, former spouse, sibling, niece, nephew,
mother-in-law, father-in-law, son-in law, daughter-in-law,
brother-in-law, or sister-in-law, including adoptive relationships,
Domestic Partner, a trust in which such persons (or the Grantee)
have more than 50% of the beneficial interest, a foundation in
which such persons (or the Grantee) control the management of
assets, and any other entity in which such persons (or the Grantee)
own more than fifty percent (50%) of the voting
interests.
(x) “ Incentive Stock
Option ” means an Option intended to qualify as an
incentive stock option within the meaning of Section 422 of
the Code and the regulations promulgated thereunder.
4
(y) “ Non-statutory Stock
Option ” means an Option not intended to qualify as an
Incentive Stock Option.
(z) “ Officer ”
means a person who is an officer of the Company or a Related Entity
within the meaning of Section 16 of the Exchange Act and the
rules and regulations promulgated thereunder.
(aa) “ Option ”
means an option to purchase Shares pursuant to an Award Agreement
granted under the Plan.
(bb) “ Parent ”
means a “parent corporation”, whether now or hereafter
existing, as defined in Section 424(e) of the Code.
(cc) “ Performance-Based
Compensation ” means compensation qualifying as
“performance-based compensation” under
Section 162(m) of the Code.
(dd) “ Performance Share
Units ” means an Award denominated in Shares which may be
earned in whole or in part upon attainment of performance criteria
established by the Administrator and settled in actual Shares,
except to the extent the Administrator may determine to settle such
Award in whole or in part in cash.
(ee) “ Performance Cash
Units ” means an Award denominated in U.S. dollars which
may be earned in whole or in part based upon attainment of
performance criteria established by the Administrator and settled
for cash, except to the Administrator may determine to settle such
Award in whole or in part in Shares.
(ff) “ Phantom Share
” means an Award denominated in Shares in which the Grantee
has the right to receive an amount equal to the value of a
specified number of Shares at a designated time or over a
designated period and which will be payable in cash or Shares as
established by the Administrator.
(gg) “ Plan ”
means this Gilead Sciences, Inc. 2004 Equity Incentive Plan, as
amended from time to time.
(hh) “ Related Entity
” means (i) any Parent or Subsidiary of the Company and
(ii) any corporation in an unbroken chain of corporations
beginning with the Company and ending with the corporation in the
chain for which the Grantee provides services as an Employee,
Director or Consultant, provided each corporation in such chain
owns securities representing at least twenty percent (20%) of
the total outstanding voting power of the outstanding securities of
another corporation or entity in such chain and there is a
legitimate non-tax business purpose for making an Award to such
Grantee. However, for any Award not subject to Section 409A of
the Code, a Related Entity shall also include any business,
corporation, partnership, limited liability company or other entity
in which the Company or any Parent or Subsidiary holds a
substantial ownership interest, directly or indirectly.
(ii) “ Restricted Stock
” means Shares issued under the Plan to the Grantee for such
consideration (including any cash consideration) and subject to
such restrictions on transfer, rights of first refusal, repurchase
provisions, forfeiture provisions, and other terms and conditions
as established by the Administrator.
(jj) “ Restricted Stock
Unit ” means an Award in the form of a contractual right
to receive Shares in one or more installments over a defined period
of Continuous Service or upon the attainment of one or more
performance goals established by the Administrator or in one or
more deferred installments following the completion of such period
of Continuous Service or the attainment of such performance
goals.
(kk) “ Rule 16b-3
” means Rule 16b-3 promulgated under the Exchange Act or any
successor thereto, as in effect when discretion is being exercised
with respect to the Plan.
(ll) “ SAR ”
means a stock appreciation right entitling the Grantee to Shares or
cash compensation, as established by the Administrator, measured by
appreciation in the value of the Common Stock underlying such
Award.
(mm) “ Share ”
means a share of the Common Stock.
(nn) “ Subsidiary
” means a “subsidiary corporation”, whether now
or hereafter existing, as defined in Section 424(f) of the
Code.
(oo) “ Withholding
Taxes ” mean the applicable federal and state income and
employment withholding taxes to which the holder of an Award under
the Plan may become subject in connection with the issuance,
exercise, vesting or settlement of that Award.
5
3. Stock Subject to the Plan
.
(a) Subject to the
provisions of Section 10 below, the maximum number of Shares
which may be issued in the aggregate under the Plan pursuant to all
Awards made hereunder (including, without limitation, Restricted
Stock, Restricted Stock Units, Performance Shares, Options, SARs,
Dividend Equivalent Rights, and Phantom Shares) shall be limited to
90,400,000 (2)
Shares, plus
31,194,183 shares that have as of May 6, 2009 been transferred
in the aggregate to the 2004 Plan from the previously-authorized
but unissued reserve under the Gilead Sciences, Inc. 1991 Stock
Option Plan and the Gilead Sciences, Inc. 1995 Non-Employee
Directors’ Stock Option Plan, including shares that were
available for future award under such plans on May 25, 2004,
the date the stockholders approved the 2004 Plan, and shares
subject to awards outstanding under those plans on that date that
have subsequently terminated or expired without the issuance of
vested shares thereunder. Notwithstanding the foregoing, no more
than 25,000,000 of such Shares may be issued over the term of the
Plan pursuant to all Awards of Restricted Stock, Restricted Stock
Units, Performance Shares, Performance Units (to the extent settled
in Shares) and Phantom Shares, in total. (3)
The Shares to be
issued pursuant to Awards may be authorized, but unissued, or
reacquired Common Stock. Performance Units that by their terms may
only be settled in cash shall neither reduce the maximum aggregate
number of Shares that may be issued under the Plan nor be counted
against the foregoing 25,000,000-Share limit imposed with respect
to certain types of Awards.
(b) Any Shares covered by an Award
(or portion of an Award) which is forfeited, canceled or expires
(whether voluntarily or involuntarily) shall be deemed not to have
been issued for purposes of determining the maximum aggregate
number of Shares which may be issued under the Plan. Shares that
actually have been issued under the Plan pursuant to an Award shall
not be returned to the Plan and shall not become available for
future issuance under the Plan, except that if unvested Shares are
forfeited, or repurchased by the Company at the lower of their
original purchase price or their Fair Market Value at the time of
repurchase, such Shares shall become available for future grant
under the Plan. Should the exercise price of an option under the
Plan be paid with shares of Common Stock, then the authorized
reserve of Common Stock under the Plan shall be reduced by the
gross number of shares for which that option is exercised, and not
by the net number of shares issued under the exercised stock
option. Upon the exercise of any SAR under the Plan, the share
reserve shall be reduced by the gross number of shares as to which
such right is exercised, and not by the net number of shares
actually issued by the Company upon such exercise. If shares of
Common Stock otherwise issuable under the Plan are withheld by the
Company in satisfaction of the withholding taxes incurred in
connection with the issuance, exercise, vesting or settlement of an
Award, then the number of shares of Common Stock available for
issuance under the Plan shall be reduced by the gross number of
Shares issuable at that time under such Award, calculated in each
instance prior to any such share withholding.
|
(2)
|
Maximum number of Shares
consists of 3,600,000 Shares authorized coincident with the
adoption of the 2004 Equity Incentive Plan at the 2004 annual
stockholders meeting, another 3,600,000 Shares due to the share
adjustment for the two-for-one stock split effective
September 3, 2004, an additional 10,000,000 Shares authorized
and approved at the 2005 annual stockholders meeting, an additional
10,000,000 Shares authorized and approved at the 2006 annual
stockholders meeting, an additional 3,000,000 Shares authorized and
approved at the 2007 annual stockholders meeting, another
30,200,000 Shares due to the share adjustment for the two-for-one
stock split effective June 22, 2007, an additional 10,000,000
Shares authorized and approved at the 2008 annual stockholders
meeting and an additional 20,000,000 Shares authorized and approved
at the 2009 annual stockholders meeting.
|
|
(3)
|
The increase to this limit from
10,000,000 Shares to 25,000,000 Shares was approved by the Board on
January 21, 2009 and approved by the stockholders at the 2009
annual stockholders meeting. The 25,000,000 Share limit will also
apply to Performance Units to the extent these Awards are settled
in Shares. The Company has never declared nor paid a cash dividend
and does not intend to grant any dividend equivalent rights in the
foreseeable future; however, if a dividend equivalent right were to
be granted in the future, the Company would consider the number of
Shares as to which such dividend equivalent rights may be granted
as subject to the 25,000,000 Share limit.
|
6
4. Administration of the
Plan.
(a) Plan Administrator
:
(i) Administration with Respect
to Directors and Officers . With respect to grants of Awards to
Directors or Employees who are also Officers or Directors of the
Company, the Plan shall be administered by (A) the Board or
(B) a Committee designated by the Board, which Committee shall
be constituted in such a manner as to satisfy the Applicable Laws
and to permit such grants and related transactions under the Plan
to be exempt from Section 16(b) of the Exchange Act in
accordance with Rule 16b-3. Once appointed, such Committee shall
continue to serve in its designated capacity until otherwise
directed by the Board. With respect to the grant of an Award to a
Director who is not an Employee and which is not a scheduled Award
under predetermined rules established by the Board or Committee,
such grant shall be made only by a Committee (or subcommittee of
the Committee) which is comprised solely of two or more
Non-Employee Directors, as this term is defined in Rule 16b-3, none
of whom are the recipient of the Award.
(ii) Administration With Respect
to Consultants and Other Employees . With respect to grants of
Awards to Employees or Consultants who are neither Directors nor
Officers of the Company, the Plan shall be administered by
(A) the Board or (B) a Committee designated by the Board,
which Committee shall be constituted in such a manner as to satisfy
the Applicable Laws. Once appointed, such Committee shall continue
to serve in its designated capacity until otherwise directed by the
Board. The Board may authorize one or more Officers of the Company
or any Parent to grant such Awards, subject to such terms and
conditions as the Board may impose; provided, however, that any
delegation of such authority shall in all events be subject to the
limitations and restrictions of Applicable Laws, including any
required limitation on the maximum of Shares for which Awards may
be made by such Officer or Officers.
(iii) Administration With Respect
to Covered Employees . Notwithstanding the foregoing, grants of
Awards to any Covered Employee intended to qualify as
Performance-Based Compensation shall be made only by a Committee
(or subcommittee of a Committee) which is comprised solely of two
or more Directors eligible to serve on a committee making Awards
qualifying as Performance-Based Compensation. In the case of such
Awards granted to Covered Employees, references to the
“Administrator” or to a “Committee” shall
be deemed to be references to such Committee or
subcommittee.
(b) Powers of the
Administrator : Subject to Applicable Laws and the provisions
of the Plan (including any other powers given to the Administrator
hereunder), and except as otherwise provided